Letter to the Editor
Intravenously Injected Recombinant Human Type VII Collagen Homes to Skin Wounds and Restores Skin Integrity of Dystrophic Epidermolysis Bullosa

https://doi.org/10.1038/jid.2013.10Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Dr Mei Chen and Dr David Woodley are consultants for Lotus Tissue Repair, Inc. and hold stock in the company. Dr Mei Chen, Dr David T. Woodley, and the University of Southern California hold patents for recombinant type VII collagen and have filed a Conflict of Interest Declaration with Dr Randoph W. Hall, Vice Provost for Research Advancement at the University of Southern California.